Barman, that other stock is not making a vaccine. You didn't read well. I also stated that MSB's other achievements will continue. You didn't read that either.
To be simpler, ARDS is what is the motivation here, and MSB's solution is wonderful. One day though in the longer term, a vaccine will be developed from E. In the meantime, an antiviral targeting the E Protein is likely to be developed beforehand. But nothing will stop MSB getting a big hit in the immediate future. Simple. That's why I bought. When the other one gets its hit, you can thank me then.
You wanna play with FIRE?, page-53
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |